|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||51.19 - 54.06|
|52 Week Range||45.45 - 72.61|
|Beta (5Y Monthly)||1.20|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 23, 2022 - Feb 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||64.53|
Boston, MA, based Investment company Frontier Capital Management Co Llc (Current Portfolio) buys Wolfspeed Inc, Fair Isaac Corp, The Trade Desk Inc, II-VI Inc, Arista Networks Inc, sells Block Inc, Twilio Inc, Quanta Services Inc, Moderna Inc, Stericycle Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Frontier Capital Management Co Llc.
NuVasive's (NUVA) Attrax Putty is the first and only synthetic biologic to receive 510(k) indications for use in interbody fusions of the thoracolumbar spine.
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company received U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax® Putty with its comprehensive thoracolumbar interbody portfolio for spine surgery. Attrax Putty is the first synthetic biologic to receive indications for use in interbody fusions of the th